Opening book details…
About this Neuroscience article
Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements by Karl Broich; Marco Weiergräber; Harald Hampel is a Neuroscience article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Neuroscience.
- Author
- Karl Broich; Marco Weiergräber; Harald Hampel
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0301-0082)
- Published
- 2011
- Field
- Neuroscience (Life Sciences)
More by Karl Broich; Marco Weiergräber; Harald Hampel
Browse all works by Karl Broich; Marco Weiergräber; Harald Hampel